STAAR Surgical Company (STAA)
Solvency ratios
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 1.28 | 1.27 | 1.25 | 1.34 | 1.31 |
STAAR Surgical Company has consistently maintained a very healthy solvency position, as indicated by its solvency ratios. The debt-to-assets ratio, debt-to-capital ratio, and debt-to-equity ratio have all remained at 0.00 over the past five years, suggesting that the company operates with minimal debt in relation to its assets, capital, and equity.
Furthermore, the financial leverage ratio has shown slight fluctuations over the same period, ranging from 1.25 to 1.34. This ratio indicates that the company's financial leverage, or the use of debt to finance operations, is moderate and has remained relatively stable.
Overall, STAAR Surgical Company's solvency ratios reflect a strong financial position with low debt levels and a conservative approach to financial leverage. Investors and stakeholders can be reassured by the company's solid solvency metrics.
Coverage ratios
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Interest coverage | — | — | 17.89 | — | 2.87 |
The interest coverage ratio measures a company's ability to meet its interest obligations on outstanding debt. Looking at STAAR Surgical Company's data, we can observe a fluctuating trend in the interest coverage ratio over the years.
As of December 31, 2020, the interest coverage ratio was 2.87, indicating that the company's operating income was able to cover its interest expenses approximately 2.87 times. However, there is a missing data point for December 31, 2021, making it challenging to assess the company's performance in that particular year.
Moving forward, the interest coverage ratio significantly improved to 17.89 as of December 31, 2022. This sharp increase suggests a stronger ability to cover interest expenses, indicating potential improved financial health and lower default risk.
Unfortunately, data points for December 31, 2023, and December 31, 2024 are missing, preventing a complete analysis of the interest coverage trend in those years.
In conclusion, based on the available data, STAAR Surgical Company demonstrated varying levels of interest coverage over the years, with notable improvements in certain periods. However, the missing data for some years hinders a comprehensive assessment of the company's long-term ability to meet its interest obligations. It would be beneficial to monitor future financial reports to gain a clearer understanding of STAAR Surgical Company's interest coverage performance.